8Saif MW,Katirtzoglou NA,Syrigos KS.Capecitabine:an overview of the side dffects and their management[J].Anticancer Drugs,2008,19(5):447-464.
9Giuliani G,Falcone A,Garrison L.Economic evaluation of the cost of treating advanced gastric cancer(AGC)with capecitabine/cisplatin(XP)vs.5-FU/cispLatin(FP)regimens in an Italian setting.J Clin Oncol,2007,25(18s):15022.
10Marshall J,Sun J,Norris C.Safety of chronic low dose capecitabine as maintenance therapy in GI cancers.2007 ASCO Gastrointestinal Cancers Symposium:abstract 166.
